Browse the full insider trade history of HLB테라퓨틱스, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, HLB테라퓨틱스 has published 5 insider filings. Market capitalisation: €264.9bn. The latest transaction was reported on 21 April 2026 — Other. Among the most active insiders: HLB. All data is accessible without an account.